title: Limitations of peptide retro-inverso isomerization in molecular mimicry.
abstract: A retro-inverso peptide is made up of d-amino acids in a reversed sequence and, when extended, assumes a side chain topology similar to that of its parent molecule but with inverted amide peptide bonds. Despite their limited success as antigenic mimicry, retro-inverso isomers generally fail to emulate the protein-binding activities of their parent peptides of an alpha-helical nature. In studying the interaction between the tumor suppressor protein p53 and its negative regulator MDM2, Sakurai et al. (Sakurai, K., Chung, H. S., and Kahne, D. (2004) J. Am. Chem. Soc. 126, 16288-16289) made a surprising finding that the retro-inverso isomer of p53(15-29) retained the same binding activity as the wild type peptide as determined by inhibition enzyme-linked immunosorbent assay. The authors attributed the unusual outcome to the ability of the D-peptide to adopt a right-handed helical conformation upon MDM2 binding. Using a battery of biochemical and biophysical tools, we found that retro-inverso isomerization diminished p53 (15-29) binding to MDM2 or MDMX by 3.2-3.3 kcal/mol. Similar results were replicated with the C-terminal domain of HIV-1 capsid protein (3.0 kcal/mol) and the Src homology 3 domain of Abl tyrosine kinase (3.4 kcal/mol). CD and NMR spectroscopic as well as x-ray crystallographic studies showed that D-peptide ligands of MDM2 invariably adopted left-handed helical conformations in both free and bound states. Our findings reinforce that the retro-inverso strategy works poorly in molecular mimicry of biologically active helical peptides, due to inherent differences at the secondary and tertiary structure levels between an l-peptide and its retro-inverso isomer despite their similar side chain topologies at the primary structure level.
authors.affiliation: School of Pharmacy, Fudan University, Shanghai 201203, China.
authors.forename: Chong
authors.initials: C
authors.lastname: Li
authors.forename: Marzena
authors.initials: M
authors.lastname: Pazgier
authors.forename: Jing
authors.initials: J
authors.lastname: Li
authors.forename: Changqing
authors.initials: C
authors.lastname: Li
authors.forename: Min
authors.initials: M
authors.lastname: Liu
authors.forename: Guozhang
authors.initials: G
authors.lastname: Zou
authors.forename: Zhenyu
authors.initials: Z
authors.lastname: Li
authors.forename: Jiandong
authors.initials: J
authors.lastname: Chen
authors.forename: Sergey G
authors.initials: SG
authors.lastname: Tarasov
authors.forename: Wei-Yue
authors.initials: WY
authors.lastname: Lu
authors.forename: Wuyuan
authors.initials: W
authors.lastname: Lu
mesh_terms: D002213:Capsid / Q000737:chemistry; D018797:Cell Cycle Proteins; D018360:Crystallography, X-Ray / Q000379:methods; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D015497:HIV-1 / Q000378:metabolism; D006801:Humans; D008958:Models, Molecular; D018716:Molecular Mimicry / Q000187:drug effects; D009687:Nuclear Proteins / Q000737:chemistry; D010455:Peptides / Q000737:chemistry*; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D011518:Proto-Oncogene Proteins / Q000737:chemistry; D051736:Proto-Oncogene Proteins c-mdm2 / Q000737:chemistry; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry; D044767:Ubiquitin-Protein Ligases / Q000737:chemistry
chemical_list: D018797:Cell Cycle Proteins; C482775:MDM4 protein, human; D009687:Nuclear Proteins; D010455:Peptides; D011518:Proto-Oncogene Proteins; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2; D044767:Ubiquitin-Protein Ligases
references.citation: Cell. 1995 Jan 27;80(2):237-48
references.pmid: 7834743
references.citation: Nat Struct Mol Biol. 2005 Aug;12(8):671-7
references.pmid: 16041387
references.citation: Science. 1996 Mar 29;271(5257):1854-7
references.pmid: 8596952
references.citation: J Mol Biol. 1997 Jun 27;269(5):744-56
references.pmid: 9223638
references.citation: J Biomol NMR. 1995 Nov;6(3):277-93
references.pmid: 8520220
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4665-70
references.pmid: 19255450
references.citation: J Biomol NMR. 2002 Nov;24(3):171-89
references.pmid: 12522306
references.citation: J Immunol. 2003 Feb 1;170(3):1362-73
references.pmid: 12538696
references.citation: Acta Crystallogr D Biol Crystallogr. 1999 Jan;55(Pt 1):85-92
references.pmid: 10089398
references.citation: J Cell Sci. 2001 Apr;114(Pt 7):1253-63
references.pmid: 11256992
references.citation: J Am Chem Soc. 2006 Jan 25;128(3):809-16
references.pmid: 16417370
references.citation: Chem Biol Drug Des. 2007 Dec;70(6):552-6
references.pmid: 17999664
references.citation: Nature. 2007 Dec 13;450(7172):1001-9
references.pmid: 18075579
references.citation: Nat Rev Cancer. 2009 Dec;9(12):862-73
references.pmid: 19935675
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5762-7
references.pmid: 18391200
references.citation: J Mol Biol. 2010 Apr 30;398(2):200-13
references.pmid: 20226197
references.citation: Science. 1997 Oct 31;278(5339):849-53
references.pmid: 9346481
references.citation: Angew Chem Int Ed Engl. 2009;48(46):8712-5
references.pmid: 19827079
references.citation: J Mol Recognit. 2003 May-Jun;16(3):131-8
references.pmid: 12833568
references.citation: Science. 1996 Nov 8;274(5289):948-53
references.pmid: 8875929
references.citation: Adv Protein Chem. 2002;61:119-60
references.pmid: 12461823
references.citation: Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83
references.pmid: 17380161
references.citation: Nat Rev Drug Discov. 2004 Apr;3(4):301-17
references.pmid: 15060526
references.citation: Nature. 1994 Nov 24;372(6504):375-9
references.pmid: 7802869
references.citation: Curr Opin Chem Biol. 2008 Jun;12(3):292-6
references.pmid: 18423417
references.citation: Cancer Res. 2007 Sep 15;67(18):8810-7
references.pmid: 17875722
references.citation: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16828-33
references.pmid: 17942675
references.citation: Cell. 1994 Mar 11;76(5):933-45
references.pmid: 7510218
references.citation: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references.pmid: 15299926
references.citation: Science. 2004 Feb 6;303(5659):844-8
references.pmid: 14704432
references.citation: Biochem Biophys Res Commun. 2007 Dec 21;364(3):608-13
references.pmid: 17963728
references.citation: Methods Enzymol. 1997;276:307-26
references.pmid: 27754618
references.citation: J Am Chem Soc. 2004 Dec 22;126(50):16288-9
references.pmid: 15600307
references.citation: Nat Rev Cancer. 2003 Feb;3(2):102-9
references.pmid: 12563309
references.citation: J Biol Chem. 2010 Jan 15;285(3):2174-83
references.pmid: 19910468
references.citation: Angew Chem Int Ed Engl. 2010 May 10;49(21):3649-52
references.pmid: 20449836
references.citation: Biochemistry. 1996 Aug 20;35(33):10634-40
references.pmid: 8718852
references.citation: Annu Rev Biochem. 2000;69:923-60
references.pmid: 10966479
references.citation: Cell. 2007 Oct 5;131(1):70-9
references.pmid: 17923088
references.citation: J Virol. 1994 Dec;68(12):8180-7
references.pmid: 7966609
references.citation: Chembiochem. 2003 Aug 4;4(8):748-53
references.pmid: 12898626
references.citation: Nature. 1992 Jul 2;358(6381):15-6
references.pmid: 1614522
references.citation: Biochemistry. 2001 Jul 31;40(30):8981-9
references.pmid: 11467960
references.citation: Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):180-93
references.pmid: 1478777
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3933-8
references.pmid: 18316739
references.citation: Curr Opin Biotechnol. 1998 Aug;9(4):377-82
references.pmid: 9720264
references.citation: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9765-9
references.pmid: 7937888
references.citation: J Biomol NMR. 1992 Nov;2(6):661-5
references.pmid: 1490109
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: J Biol Chem. 2006 Nov 3;281(44):33030-5
references.pmid: 16905541
references.citation: Virology. 1998 Nov 10;251(1):1-15
references.pmid: 9813197
references.citation: Nature. 1995 Feb 16;373(6515):573-80
references.pmid: 7531822
references.citation: J Pept Res. 2003 Aug;62(2):53-62
references.pmid: 12823617
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Mar;60(Pt 3):432-8
references.pmid: 14993666
references.citation: Science. 1994 Nov 4;266(5186):776-9
references.pmid: 7973629
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14116-21
references.pmid: 12381794
references.citation: J Cell Sci. 2007 Feb 1;120(Pt 3):371-8
references.pmid: 17251377
references.citation: Nat Struct Mol Biol. 2005 Aug;12(8):678-82
references.pmid: 16041386
references.citation: Curr Protein Pept Sci. 2003 Oct;4(5):339-56
references.pmid: 14529528
references.citation: J Magn Reson. 2003 Jan;160(1):65-73
references.pmid: 12565051
references.citation: J Mol Biol. 2002 Oct 25;323(3):491-501
references.pmid: 12381304
references.citation: Annu Rev Biochem. 1963;32:269-300
references.pmid: 14140703
references.citation: Biopolymers. 1997;43(5):383-400
references.pmid: 9566119
references.citation: Biopolymers. 2007;88(5):657-86
references.pmid: 17427181
references.citation: Cell. 1999 Oct 1;99(1):103-15
references.pmid: 10520998
references.citation: Arch Biochem Biophys. 2000 Sep 15;381(2):278-84
references.pmid: 11032416
references.citation: Nat Rev Cancer. 2006 Dec;6(12):909-23
references.pmid: 17128209
references.citation: Protein Sci. 1995 Nov;4(11):2411-23
references.pmid: 8563639
references.citation: J Am Chem Soc. 2008 Oct 15;130(41):13546-8
references.pmid: 18798622